Drug-induced QRS morphology and duration changes

Cardiology Journal

Volumn 15, Issue 6, 2008, Pages 505-509

  Madias, John E ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Drug induced ECG changes; Drug induced QRS amplitude changes; Drug induced QRS duration changes; Drug induced QRS morphology changes; ECG; QRS duration

Indexed keywords

AMIODARONE; AMITRIPTYLINE; ANALGESIC AGENT; ANTIARRHYTHMIC AGENT; ANTIDIABETIC AGENT; ANTIMALARIAL AGENT; ASTEMIZOLE; AZIMILIDE; BENZODIAZEPINE; CISAPRIDE; DAUNORUBICIN; DESIPRAMINE; DISOPYRAMIDE; DOFETILIDE; DOSULEPIN; DOXORUBICIN; FLECAINIDE; LIDOCAINE; MAPROTILINE; MEXILETINE; MORACIZINE; NEUROLEPTIC AGENT; PHENYTOIN; PILSICAINIDE; PROCAINAMIDE; PROPAFENONE; QUINIDINE; TOCAINIDE; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG;

CARDIOTOXICITY; DEPRESSION; DRUG MECHANISM; DRUG SAFETY; ECG ABNORMALITY; ELECTROCARDIOGRAM; EVENT RELATED POTENTIAL; HEART ARRHYTHMIA; HEART DEPOLARIZATION; HOLTER MONITORING; HUMAN; P WAVE; PERIPHERAL EDEMA; PHARMACODYNAMICS; QRS COMPLEX; QT INTERVAL; QT PROLONGATION; REVIEW; SIDE EFFECT; SODIUM TRANSPORT; STANDARDIZATION; VECTORCARDIOGRAPHY;

ANTI-ARRHYTHMIA AGENTS; ANTIDEPRESSIVE AGENTS; ARRHYTHMIAS, CARDIAC; ELECTROCARDIOGRAPHY; HEART RATE; HISTAMINE ANTAGONISTS; HUMANS;

EID: 59849100145     PISSN: 18975593     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (29)

1. Zareba W, Lin DA. Antipsychotic drugs and QT interval prolongation. Psychiatr Q, 2003; 74: 291-306.
2. Macfarlane PW, Veitch Lawrie TD eds. Comprehensive electrocardiology. Theory and practice in health and disease. Pergamon Press, New York, pp. 140, 440, 450, 1147, 1442, 12533.
3. Kulakowski P, Bashir Y, Heald S et al. Prediction of antiarrhythmic efficacy of class I and III agents in patients with ventricular tachycardia by signal-averaged ECG analysis. Pacing Clin Electrophysiol, 1992; 15: 2116-2121.
4. Greenspon AJ, Kidwell GA, DeCaro M et al. The effects of type I antiarrhythmic drugs on the signal-averaged electrocardiogram in patients with malignant ventricular arrhythmias. Pacing Clin Electrophysiol, 1992; 15: 1445-1453.
5. Greenspon AJ, Kidwell GA. The effects of antiarrhythmic drugs on the signal-averaged electrocardiogram in patients with malignant ventricular arrhythmias. Prog Cardiovasc Dis, 1993; 35: 399-406.
6. Sutovsky I, Katoh T, Takayama H et al. Therapeutic monitoring of class I antiarrhythmic agents using high-resolution electrocardiography instead of blood samples. Circ J, 2003; 67: 195-198.
7. Brembilla-Perrot B, Claudon O, Houriez P et al. Absence of change of signal-averaged electrocardiogram identifies patients with ventricular arrhythmias who are non-responders to amiodarone. Int J Cardiol, 2002; 83: 47-55.
8. Karam R, Marcello S, Brooks RR et al. Azimilide dihydrochloride, a novel antiarrhythmic agent. Am J Cardiol, 1998; 81: 40D.
9. Afshari R, Maxwell S, Dawson A et al. ECG abnormalities in coproxamol (paracetamol/dextropropoxyphene) poisoning. Clin Toxicol (Philadelphia), 2005; 43: 255-259.
10. Honig PK, Wortham DC, Hull R et al. Itraconazole affects single-dose terfenadine pharmacokinetics and cardiac repolarization pharmacodynamics. J Clin Pharmacol, 1993; 33: 1201-1206.
11. Zamora SA, Belli DC, Ferrazzini G et al. Effects of cisapride on ventricular depolarization-repolarization and arrhythmia markers in infants. Biol Neonate, 2001; 80: 30-34.
12. Kresse-Hermsdorf M, Müller-Oerlinghausen B. Tricyclic neuroleptic and antidepressant overdose: Epidemiological, electrocardiographic, and clinical features: A survey of 92 cases. Pharmacopsychiatry, 1990; 23 (suppl. 1): 17-22.
13. Thanacoody HK, Thomas SH. Tricyclic antidepressant poisoning: cardiovascular toxicity. Toxicol Rev, 2005; 24: 205-214.
14. Palha AP, Ferreira L, Abreu-Lima C et al. A double-blind trial comparing mianserin and maprotiline in depressed inpatients. Clin Ther, 1985; 7: 584.
15. Veith RC, Friedel RO, Bloom V et al. Electrocardiogram changes and plasma desipramine levels during treatment of depression. Clin Pharmacol Ther, 1980; 27: 796-802.
16. Harrigan RA, Brady WJ. ECG abnormalities in tricyclic antidepressant ingestion. Am J Emerg Med, 1999; 17: 387-393.
17. Weaver SK, Fulkerson PK, Lewis RP, Leier CV. A paucity of chronic electrocardiographic changes with adriamycin therapy. J Electrocardiol, 1978; 11: 233-238.
18. Goldberger AL, Bhargava V. QRS duration measurement using high-frequency electrocardiography: applications and limitations of a new technique. Comput Biomed Res, 1982; 15: 474-484.
19. Bhargava V, Goldberger AL. New method for measuring QRS duration using high-frequency electrocardiography. Am J Physiol, 1982; 242: H507.
20. Nattel S, Jing W. Rate-dependent changes in intraventricular conduction produced by procainamide in anesthetized dogs. A quantitative analysis based on the relation between phase 0 inward current and conduction velocity. Circ Res, 1989; 65: 1485-1498.
21. Brembilla-Perrot B. Correlation between inducibility of sustained ventricular tachycardia and QRS duration. Eur Heart J, 1994; 15: 26-31.
22. Turrini P, Corrado D, Basso C et al. Dispersion of ventricular depolarization-repolarization: A noninvasive marker for risk stratification in arrhythmogenic right ventricular cardiomyopathy. Circulation, 2001; 103: 3075-3080.
23. Kjekshus J, Bathen J, Orning OM et al. A double-blind, cross-over comparison of flecainide acetate and disopyramide phosphate in the treatment of ventricular premature complexes. Am J Cardiol, 1984; 53: 72B.
24. Pellinen TJ, Färkkilä M, Heikkilä J et al. Electrocardiographic and clinical features of tricyclic antidepressant intoxication. A survey of 88 cases and outlines of therapy. Ann Clin Res, 1987; 19: 12-17.
25. Madias JE, Bazaz R, Agarwal H et al. Anasarca-mediated attenuation of the amplitude of electrocardiogram complexes: A description of a heretofore unrecognized phenomenon. J Am Coll Cardiol, 2001; 38: 756-764.
26. Madias JE, Madias NE. Reversible attenuation of the ECG voltage due to peripheral edema associated with treatment with a COX-2 inhibitor. Congest Heart Fail, 2006; 12: 46-50.
27. Madias JE. Unpublished data.
28. Madias JE. Significance of shortening of the mean QRS duration of the standard electrocardiogram in patients developing peripheral edema. Am J Cardiol, 2002; 89: 1444-1446.
29. Madias JE, Macfarlane PW. Artificial attenuation of ECG voltage produces shortening of the corresponding QRS duration: clinical implications for patients with edema. Pacing Clin Electrophysiol, 2005; 28: 1060-1065.